All CE Courses | POWER-PAK C.E.®
Advertisement

Sort CE Courses


Pharmacists = Pharmacists     Pharmacy Technicians = Pharmacy Technicians

CE Articles

FREE Pharmacists Invasive Mycoses in Hematologic Malignancies: Optimal Management Strategies

Supporter: Astellas and Merck & Co., Inc.
Accreditations/Hours:
ACPE / Pharm / 2.00 , ACPE / Other / 2.00
Web Publication: 4/30/2016
Expiration: 4/29/2017
Topic: Hematology , Infectious Disease , Oncology , Internal Medicine

FREE Pharmacists Update on Heart Failure Management: A Primer for Pharmacists

Supporter: Amgen, Inc.
Accreditations/Hours:
ACPE / Pharm / 2.00 , ACPE / Other / 2.00
Web Publication: 4/29/2016
Expiration: 4/30/2018
Topic: Cardiology , Internal Medicine , Primary Care , Managed Care , Long Term Care , Hospital/Health Systems

PAID Pharmacy Technicians Update on the Prescription Drug Abuse Epidemic for Pharmacists and Pharmacy Technicians

Supporter: No commercial support
Accreditations/Hours:
ACPE / Pharm Tech / 2.00 , ACPE / Other / 2.00
Web Publication: 4/29/2016
Expiration: 4/30/2018
Topic: Law

FREE Pharmacists Expanding Horizons in Immuno-Oncology: Health System Pharmacists’ Perspectives – Case 2: The Role of Checkpoint Inhibitors in NSCLC: Ushering a New Era in Treatment

Supporter: Bristol-Myers Squibb
Accreditations/Hours:
ACPE / Pharm / 0.50 , ACPE / Other / 0.50
Web Publication: 4/29/2016
Expiration: 4/29/2017
Topic: Dermatology , Gastroenterology , Hematology , Nephrology , Oncology , Pulmonology , Urology , Specialty Pharmacy , Managed Care , Hepatic/Biliary Disorders

FREE Pharmacists Expanding Horizons in Immuno-Oncology: Health System Pharmacists' Perspectives

Supporter: Bristol-Myers Squibb
Accreditations/Hours:
ACPE / Pharm / 1.50 , ACPE / Other / 1.50
Web Publication: 4/1/2016
Expiration: 4/1/2017
Topic: Dermatology , Gastroenterology , Hematology , Nephrology , Oncology , Pulmonology , Urology , Specialty Pharmacy , Managed Care , Hepatic/Biliary Disorders

FREE Pharmacists Expanding Horizons in Immuno-Oncology: Health System Pharmacists’ Perspectives Case 1: The New Immune Checkpoint Inhibitors: Toward a Cure for Metastatic Melanoma

Supporter: Bristol-Myers Squibb
Accreditations/Hours:
ACPE / Pharm / 0.50 , ACPE / Other / 0.50
Web Publication: 3/31/2016
Expiration: 3/31/2017
Topic: Dermatology , Gastroenterology , Hematology , Nephrology , Oncology , Pulmonology , Urology , Specialty Pharmacy , Managed Care , Hepatic/Biliary Disorders

First Previous Next Last 
Showing 1 to 6 (of 119 records)